Patent application EP19912225A (EP), filed 2019-08-16
Publication number: EP3752524A1
Title: ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES
IPC codes: C12N  15/   864            A I
C07K  14/   705            A I
C07K  14/    72            A I
A61K  48/    00            A I
A61P  27/    02            A I
A61P   9/    10            A I
C12N  15/    86            A I
Office action: search_report, dated 2020-12-23
Rejection reasons: novelty_epc_54
inventive_step_epc_56
Prior art cited: ref_id: WO2014134627
ref_type: patent
severity: background
ref_id: US2017348387
ref_type: patent
severity: obviousness
ref_id: WO2020180928
ref_type: patent
severity: novelty_destroying
ref_id: WO2020206098
ref_type: patent
severity: novelty_destroying
ref_id: - HAIDER NEENA B ET AL, "Master Modifier Nr2e3 Rescues Disease and Promotes Retina Homeostasis in Multiple Models of RP", vol. 58, no. 8, (20170601), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, URL: https://iovs.arvojournals.org/article.aspx?articleid=2639444, XP055851381 [X] 1-4,10-11,15 * abstract * [Y] 5-9,12-14
ref_type: npl
severity: novelty_destroying
ref_id: - AMIRMOHSEN ARBABI ET AL, "Gene Therapy for Inherited Retinal Degeneration", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, US, (20190301), vol. 35, no. 2, doi:10.1089/jop.2018.0087, ISSN 1080-7683, pages 79 - 97, XP055629986 [Y] 5-9 * page  84  - page  86; figure 1 *
ref_type: npl
severity: obviousness
ref_id: - RODRIGUES GERARD A ET AL, "Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, vol. 36, no. 2, doi:10.1007/S11095-018-2554-7, ISSN 0724-8741, (20181227), pages 1 - 20, (20181227), XP036689467 [A] 1-15 * the whole document *
ref_type: npl
severity: background
Final disposition: pending (2020-12-23)